UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Clinical implementation of a paediatric 3D-printed combination of Sulfamethoxazole and Trimethoprim

Stoops, Maxime; Do, Bernard; Ramos, Stéphanie; Tan, Bing Xun; Sheng Chua, Nicholas Yong; Mazet, Roseline; Guiblin, Nicolas; ... Annereau, Maxime; + view all (2025) Clinical implementation of a paediatric 3D-printed combination of Sulfamethoxazole and Trimethoprim. International Journal of Pharmaceutics , 676 , Article 125581. 10.1016/j.ijpharm.2025.125581. Green open access

[thumbnail of 1-s2.0-S0378517325004181-main.pdf]
Preview
Text
1-s2.0-S0378517325004181-main.pdf - Published Version

Download (8MB) | Preview

Abstract

Adherence to treatment is one of the major challenges in chronic diseases. Inappropriate dosage forms or bad taste are the main factor for non-adherence, especially in paediatric patients. 3D printed medicines could be tailored to specific patients to make medicines more acceptable, however the clinical implementation in hospitals is still limited. This study addresses the challenge of developing pharma-inks (mixtures of drugs and excipients) for semi-solid extrusion (SSE) to produce chewable tablets of Sulfamethoxazole (SMX) and Trimethoprim (TMP) for paediatric oncology patients in a hospital setting. SMX and TMP pharma-inks were stable and printable on demand for more than 3 months. The chewable tablets were also stable, and the drug dissolution profiles were comparable to those of the commercial formulations, indicating potential bioequivalence. Human sensory evaluations confirmed that the formulation improved palatability compared to traditional suspensions. 3D-printed SMX/TMP formulations are an alternative to traditional formulations for paediatric patients in hospital settings, enhancing acceptability and adherence while enabling personalized dosing.

Type: Article
Title: Clinical implementation of a paediatric 3D-printed combination of Sulfamethoxazole and Trimethoprim
Location: Netherlands
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.ijpharm.2025.125581
Publisher version: https://doi.org/10.1016/j.ijpharm.2025.125581
Language: English
Additional information: © 2025 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: 3D Printing, Infrared Hyperspectral Imaging (IHI), Paediatric Medicine, Personalized Drug Delivery, Semi-Solid Extrusion (SSE)
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy
URI: https://discovery.ucl.ac.uk/id/eprint/10208551
Downloads since deposit
3Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item